Clinicaldata Invest Information

Companies
Cytokinetics Reveals Encouraging SEQUOIA-HCM Study Data at ESC Congress 2024 Sep 1, 2024
Companies
Immix Biopharma's NXC-201 Shows Promising Results for AL Amyloidosis in Clinical Study May 11, 2024